Cancer Research Horizons, the innovation arm of Cancer Research UK, has reached its £5m fundraising target for the Cancer Impact Club, a community of business builders whose philanthropy, expertise and networks is helping to shape the future of cancer treatment.
With 50 members now recruited, the Club has raised £5m to boost the impact of Cancer Research Horizons’ Seed Fund, supporting Cancer Research UK’s More Research, Less Cancer campaign to accelerate progress.
Focused on patient impact, the Seed Fund aims to tackle the funding gap faced by many early-stage cancer ventures looking to translate their innovation out of the lab and towards the clinic – particularly those focused on rare or hard-to-treat indications, such as brain, pancreatic, or children and young people’s cancers.
The fund was launched in 2022 with a £15m commitment from Cancer Research UK and is managed by Cancer Research Horizons’ dedicated Ventures team. It provides funding, business building support, and access to expert networks to accelerate early-stage treatments, devices and solutions into patient benefit.
Together with a £10m donation from Garfield Weston Foundation, donations from the Cancer Impact Club have now doubled the Seed Fund, bringing it to £30m. This generous support is enabling Cancer Research Horizons to make both a greater number and larger scale investments into high-potential, early-stage cancer ventures, as well as strengthen its ability to provide follow-on support to portfolio companies as they progress towards the clinic.
Source link
